Top Markets
Coin of the day
Hansa Biopharma AB Hansa Biopharma AB

Hansa Biopharma AB

HNSBF
Classifica tra le azioni #15162
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Prezzo delle azioni
$3.70
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$369.01M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
35.04%
Paese
SE
Scambia Hansa Biopharma AB (HNSBF)

Categoria

Storico del prezzo dell'azione per Hansa Biopharma AB (HNSBF)
Prezzo di chiusura più alto: $3.70 il 2026-08-01

Prezzo di chiusura più basso: $4.71 il 2015-03-01
Storico del prezzo dell'azione di Hansa Biopharma AB dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 7.87%
2025 -0.21%
2024 29.03%
2023 -54.16%
2022 -51.64%
2021 -65.44%
2020 200.34%
2019 -69.02%
2018 10.98%
2017 118.54%
2016 302.77%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$61.61 71.22%
US
$51.00 69.23%
SE
$194.41 42.00%
FR
$62.45 0.05%
IT
$113.45 62.73%
US